dr. machiels on pembrolizumab and chemoradiation in hnscc
Published 7 years ago • 49 plays • Length 0:51Download video MP4
Download video MP3
Similar videos
-
0:58
dr. machiels on pembrolizumab in head and neck cancer
-
1:10
dr. machiels on toxicities with pembrolizumab for head and neck cancer
-
5:34
pembrolizumab for recurrent hnscc
-
2:13
dr. malhotra on pembrolizumab during concurrent chemoradiation in nsclc
-
1:05
dr. machiels on challenges and ongoing trials in head and neck cancer
-
1:23
dr. burtness on the benefit of pembrolizumab in head and neck cancer
-
1:36
dr. seiwert on pembrolizumab in head and neck cancer
-
1:59
pembrolizumab in the treatment of head and neck cancer: is there more to the story?
-
11:47
pembrolizumab in hnscc
-
0:40
dr. vokes on selecting nivolumab or pembrolizumab for head and neck cancer treatment
-
1:00
dr. ferris on pembrolizumab and nivolumab in head and neck cancer
-
0:53
dr. sequist on pembrolizumab monotherapy in nonsquamous nsclc
-
7:01
actual use of pembrolizumab and chemotherapy in nsclc
-
6:35
pembrolizumab as first-line therapy for recurrent/metastatic head and neck cancer
-
0:57
dr. joshua m. bauml on the impact of pembrolizumab in head and neck cancer
-
0:54
dr. ferris on a trial testing adu-s100/miw815/pembrolizumab in head and neck cancer
-
1:20
comparing petosemtamab and pembrolizumab in hnscc with existing therapies
-
0:39
predicting responses to immunotherapy in head and neck cancer
-
0:42
dr. kudchadkar on immunotherapy in merkel cell carcinoma